SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-046649
Filing Date
2017-09-05
Accepted
2017-09-05 17:28:08
Documents
6
Period of Report
2017-08-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v474654_8k.htm 8-K 26318
2 EXHIBIT 10.1 v474654_ex10-1.htm EX-10.1 9611
3 EXHIBIT 99.1 v474654_ex99-1.htm EX-99.1 11526
4 GRAPHIC image_001.jpg GRAPHIC 3252
5 GRAPHIC image_002.jpg GRAPHIC 3429
6 GRAPHIC image_003.jpg GRAPHIC 3324
  Complete submission text file 0001144204-17-046649.txt   63103
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 171069653
SIC: 1000 Metal Mining